| Literature DB >> 23056294 |
Trevor L Starr1, Silvere Pagant, Chao-Wen Wang, Randy Schekman.
Abstract
Traffic of the integral yeast membrane protein chitin synthase III (Chs3p) from the trans-Golgi network (TGN) to the cell surface and to and from the early endosomes (EE) requires active protein sorting decoded by a number of protein coats. Here we define overlapping signals on Chs3p responsible for sorting in both exocytic and intracellular pathways by the coats exomer and AP-1, respectively. Residues 19DEESLL24, near the N-terminal cytoplasmically-exposed domain, comprise both an exocytic di-acidic signal and an intracellular di-leucine signal. Additionally we show that the AP-3 complex is required for the intracellular retention of Chs3p. Finally, residues R374 and W391, comprise another signal responsible for an exomer-independent alternative pathway that conveys Chs3p to the cell surface. These results establish a role for active protein sorting at the trans-Golgi en route to the plasma membrane (PM) and suggest a possible mechanism to regulate protein trafficking.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23056294 PMCID: PMC3463608 DOI: 10.1371/journal.pone.0046386
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Strains used in this study.
| Name | Genotype | Reference |
| YPH499 |
|
|
| JCY306 |
|
|
| SPY06 |
| This study |
| SPY21 |
| This study |
| SPY10 |
| This study |
| TSY49 |
| This study |
| TSY131 |
| |
| TSY178 |
| This study |
|
| ||
| TSY194 |
| This study |
|
| ||
| TSY269 |
| This study |
| TSY300 |
| This study |
| RSY3393 |
|
|
Plasmids used in this study.
| Name | Description | Source |
| pJC345 | EcoRI-SalI genomic fragment containing |
|
| pCHS3QC1 | W391R (Chs3W391R) mutation in pJC345 | This study |
| pCHS3QC2 | W391L (Chs3W391L) mutation in pJC345 | This study |
| pCHS3QC3 | W391F (Chs3W391F) mutation in pJC345 | This study |
| pCHS3QC4 | W391S (Chs3W391S) mutation in pJC345 | This study |
| pCHS3QC5 | W391A (Chs3W391A) mutation in pJC345 | This study |
| pCHS3QC6 | W391T (Chs3R374T) mutation in pJC345 | This study |
| pCHS3QC7 | W391A (Chs3R374A) mutation in pJC345 | This study |
| pCHS3QC103 | N17AQ18A (Chs3N17AQ18A) mutation in pJC345 | This study |
| pCHS3QC133 | D19A (Chs3D19A) mutation in pJC345 | This study |
| pCHS3QC135 | E20A (Chs3E20A) mutation in pJC345 | This study |
| pCHS3QC137 | E21A (Chs3E21A) mutation in pJC345 | This study |
| pCHS3QC131 | S22A (Chs3S22A) mutation in pJC345 | This study |
| pCHS3QC106 | L23A (Chs3L23A) mutation in pJC345 | This study |
| pCHS3QC107 | L24A (Chs3L24A) mutation in pJC345 | This study |
| pCHS3QC139 | R25A (Chs3R25A) mutation in pJC345 | This study |
| pCHS3QC115 | N17AQ18A (Chs3N17AQ18AW391R) mutation in pCHS3QC1 | This study |
| pCHS3QC134 | D19A (Chs3D19AW391R) mutation in pCHS3QC1 | This study |
| pCHS3QC136 | E20A (Chs3E20AW391R) mutation in pCHS3QC1 | This study |
| pCHS3QC138 | E21A (Chs3E21AW391R) mutation in pCHS3QC1 | This study |
| pCHS3QC132 | S22A (Chs3S22AW391R) mutation in pCHS3QC1 | This study |
| pCHS3QC118 | L23A (Chs3L23AW391R) mutation in pCHS3QC1 | This study |
| pCHS3QC119 | L24A (Chs3L24AW391R) mutation in pCHS3QC1 | This study |
| pCHS3QC144 | R25A (Chs3R25AW391R) mutation in pCHS3QC1 | This study |
| pD15 | chs3p deleted of N-terminal 15 AA (Δ15CHS3)subcloned in p416MET25 | This study |
| pD15WR | W391R (Δ15CHS3(W391R)) mutation in pD15 | This study |
| pD25 | chs3p deleted of N-terminal 25 AA (Δ25CHS3) subcloned in p416MET25 | This study |
| pD25WR | W391R (Δ25CHS3(W391R)) mutation in pD25 | This study |
| pJC322 | N-terminal 171AA of Chs3p GST-tagged (Chs3(1–170)) in pGEX-2T |
|
| pCHS3QC164 | D19AE21A (Chs3(1–170)D19AE21A) mutation in pJC322 | This study |
| pCHS3-2GST | Second cytosolic loop of Chs3p GST-tagged (Chs3(224–451)) in pGEX-2T | This study |
| pTS11 | L24H (Chs3-L24H) mutation in pJC345 | This study |
| pTS13 | L24F (Chs3-L24F) mutation in pJC345 | This study |
| pTS15 | L24P (Chs3-L24P) mutation in pJC345 | This study |
| pTS18 | D19N (Chs3-D19N) mutation in pJC345 | This study |
| pTS166 | DEESLLΔ (Chs3-DEESLLΔ) mutation in pJC345 | This study |
Figure 1Chs3p residues 19DEESLL24 constitute an intracellular retention signal.
(A) Ten-fold serial dilutions of chs3Δ chs6Δ cells (TSY194) expressing point mutant alleles of CHS3 that define 19DEESLL24 as an intracellular retention signal. Dilutions were spotted on YPD, ½ YPD, SC-Ura (-Ura) and SC-Ura +50 ug/ml calcofluor (-Ura +CF). (B) Chitin staining of TSY194 expressing the chs3-L24P mutant allele. (C) Ten-fold serial dilutions of TSY194 expressing alanine-scanning point mutants of Chs3p residues 17–25.
Figure 2The DEESLL signal is required for a physical interaction between AP-1 and Chs3p.
Cells of the genotype chs3Δ pep4Δ prb1Δ prc1Δ APS1-TAP (TSY131), expressing either wt Chs3p or Chs3-DEESLLΔ were grown overnight, converted to spheroplasts, and treated with the crosslinking agent DSP prior to lysis and purification of the AP-1 complex via a TAP tag. Samples were separated on a 10% polyacrylamide gel, which was visualized with sypro red stain prior to transfer to a PVDF membrane for evaluation by imunoblot. Shown is a western for Chs3p and a total protein stain for the AP-1 purification. Note that Chs3-DEESLLΔ does not copurify with AP-1.
Figure 3AP-3 is required for the intracellular retention of Chs3p.
(A) Ten-fold serial dilutions of wt (YPH499), chs6Δ (TSY49), chs6Δ apl2Δ (RSY3393), chs6Δ apl1Δ (TSY300) and chs6Δ apl6Δ (TSY269) cells on YPD, YPD + 50 ug/ml calcofluor (YPD + CF), synthetic complete medium (SC), and synthetic complete medium +50 ug/ml calcofluor (SC + CF). (B) An average of 5 quantitative chitin assays. Cultures were grown to saturation and cell walls were isolated by lysing 35–50 mg of cells in 6% KOH. Chitin was digested with chitinase from T. viride and the resulting GlcNAc was quantified. For each assay the results of 2–3 replicates of each strain were averaged and normalized against the wt level of chitin. Five separate normalized experiments were then averaged together.
Figure 4Mutations in residues R374 and W391 specifically impair access to the alternative exocytic pathway.
(A) Ten-fold serial dilutions of chs3Δ (RSY1699) or chs3Δ chs6Δ AP-1Δ (SPY10) cells expressing alanine-substitution mutants of CHS3 were spotted onto synthetic complete medium -Ura + 100 ug/ml calcofluor (-Ura + CF). (B) Subcellular fractionation of wt Chs3, Chs3-W391R and Chs3-R374A expressed in chs3Δ and chs3Δ chs6Δ AP-1Δ cells on step sucrose/EDTA gradients. Total membranes from spheroplasts were separated on a step sucrose/EDTA gradient. The protein composition of fractions obtained from differential centrifugations and sucrose gradients were analyzed by SDS/PAGE and immunoblotting (PM marker: Pma1p; Golgi/EE markers: Tlg1p).
Figure 5Mutations of D19 and E21 result in intracellular retention of Chs3p.
(A) Ten-fold serial dilutions of chs3Δ (RSY1699) or chs3Δ AP-1Δ (SPY21) cells expressing N-terminal deletion mutants of CHS3, with and without the W391R substitution, were spotted onto synthetic complete medium -Ura plates +100 ug/ml calcofluor (-Ura + CF). (B) Ten-fold serial dilutions of chs3Δ AP-1Δ cells expressing alanine substitution mutants from residue 16 to residue 25 of Chs3-W391R were spotted onto - Ura + CF. (C) Subcellular fractionation of Δ15Chs3-W391R, Δ25Chs3-W391R and Chs3-D19AE21AW391R expressed in chs3Δ AP-1Δ cells on step sucrose/EDTA gradients. Total membranes from spheroplasts were separated on a step sucrose/EDTA gradient. The protein composition of fractions obtained from the sucrose gradients was analyzed by SDS/PAGE and immunoblotting (PM marker: Pma1p; Golgi/EE markers: Tlg1p).
Figure 6Mutation of D19 and E21 impairs the in vitro binding of Chs3p with exomer.
(A) Constructs corresponding to the full N-terminal cytosolic tail of Chs3p (Chs3 (1–170)), with and without the double substitution D19AE21A, or to the second cytosolic part of Chs3p (Chs3 (224–451)) were expressed in E. coli and purified as soluble GST-fusions. His-Chs5 and His-exomer complexes (expressed and purified from baculovirus infected culture cells [31]) were immobilized on Ni-NTA beads and incubated with 150 ug/ml purified GST-Chs3 fragments at RT for 30 min. Beads were washed and bound proteins were eluted with sample buffer followed by SDS-PAGE and Coomassie Blue staining. All samples shown were analyzed in the same gel. The images of each pertinent lane were cropped and reassembled. (B) The amount of each co-bound Chs3p fragment was quantified and normalized against the amount of Chs5p present in the same lane. The ratios of the amount of co-bound D19AE21A and 224–451 were normalized against the ratio of the wt pull-down, which was arbitrarily set to 1. The values from two independent experiments were averaged and graphed. Error bars represent standard deviations.